
Pillar to bring CertainT platform to textiles including PPE
September 21st, 2020
Pillar to bring CertainT platform to textiles including PPE
September 21st, 2020
Veterinary COVID-19 Vaccine Clinical Trial
September 16th, 2020
Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15
September 2nd, 2020
Clinical Labs: Update on Status of NYS Lab Permit
August 27th, 2020
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
August 17th, 2020
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
August 12th, 2020
Applied DNA Reports Fiscal Third Quarter 2020 Financial Results
August 6th, 2020
COVID-19 Diagnostic Kit Testing Capacity Increased by FDA EUA Amendment
July 31st, 2020
Applied DNA to Report Fiscal 2020 Third Quarter Financial Results After Market Close on August 6, 2020
July 30th, 2020